The Role of Non-Enzymatic Degradation of Meropenem-Insights from the Bottle to the Body

Liebchen, Uwe; Rakete, Sophie; Vogeser, Michael; Arend, Florian M.; Kinast, Christina; Scharf, Christina; Zoller, Michael; Schönermarck, Ulf und Paal, Michael (2021): The Role of Non-Enzymatic Degradation of Meropenem-Insights from the Bottle to the Body. In: Antibiotics-Basel, Bd. 10, Nr. 6, 715

Abstract

Several studies have addressed the poor stability of meropenem in aqueous solutions, though not considering the main degradation product, the open-ring metabolite (ORM) form. In the present work, we elucidate the metabolic fate of meropenem and ORM from continuous infusion to the human bloodstream. We performed in vitro infusate stability tests at ambient temperature with 2% meropenem reconstituted in 0.9% normal saline, and body temperature warmed buffered human serum with 2, 10, and 50 mg/L meropenem, covering the therapeutic range. We also examined meropenem and ORM levels over several days in six critically ill patients receiving continuous infusions. Meropenem exhibited a constant degradation rate of 0.006/h and 0.025/h in normal saline at 22 degrees C and serum at 37 degrees C, respectively. Given that 2% meropenem remains stable for 17.5 h in normal saline (>= 90% of the initial concentration), we recommend replacement of the infusate every 12 h. Our patients showed inter-individually highly variable, but intra-individually constant molar ORM/(meropenem + ORM) ratios of 0.21-0.52. Applying a population pharmacokinetic approach using the degradation rate in serum, spontaneous degradation accounted for only 6% of the total clearance.

• Dokumententyp: Zeitschriftenartikel
• Fakultät: Medizin
• Themengebiete: 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit
• ISSN: 2079-6382
• Sprache: Englisch